Multiple Central Giant Cell Granulomas in the mandible - A rare presentation with literature review.
Main Article Content
Abstract
Central giant cell granulomas (CGCG) are rare, benign destructive osteolytic lesion of osteoclastic origin with variable aggressiveness that occur in the maxilla and mandible. It has a peak prevalence between the ages of 10 to 25 years old with a clear preponderance for the mandible and female population. CGCG typically presents as a solitary lesion, appearing as a multilocular radiolucency with scalloped margins and a honeycomb or soap bubble like appearance. These lesions are histologically characterised by mononuclear and multinuclear giant cells on a mesenchymal stromal background. First reported by Jaffe the lesion was coined giant cell reparative granuloma; a term no longer used as understanding of the pathogenesis develops. Genetic sequencing has shown familial association and a connection with “RAS/MAPK syndromes” as they are linked by overlapping facial features and are caused by mutations at different points along the RAS/MAPK pathway. Thirty percent of CGCG present as aggressive lesions characterised by rapid growth and bone destruction. The most common treatment is surgical curettage. However, increasing knowledge of the underlying pathogenesis has led to development of non-surgical treatments such as intralesional corticosteroid injections, therapy with calcitonin, interferon and monoclonal antibodies. This paper presents the rare case of an asymptomatic 14-year-old boy with bilateral CGCG which were noted as an incidental finding on a panoramic radiographic as part of an orthodontic assessment. It was treated successfully through surgical curettage.
Downloads
Article Details
References
Orhan E, Erol S, Deren O, Sevin A, Ekici O, Erdoğan B. Idiopathic bilateral central giant cell reparative granuloma of jaws: a case report and literature review. Int J Pediatr Otorhinolaryngol. 2010 May;74(5):547-52. doi: 10.1016/j.ijporl.2010.02.006. Epub 2010 Mar 12. PMID: 20219254.
Atarbashi Moghadam S, Ghorbanpour M. Evaluation of Cyclin D1 Expression in Aggressive and Nonaggressive Central Giant Cell Granuloma of the Jaws. J Dent (Shiraz). 2018 Dec;19(4):253-258. PMID: 30680296; PMCID: PMC6338689.
Jeyaraj P. Management of Central Giant Cell Granulomas of the Jaws: An Unusual Case Report with Critical Appraisal of Existing Literature. Ann Maxillofac Surg. 2019;9(1):37-47. doi:10.4103/ams.ams_232_18
Padmavathi Devi C, Swaroopkanth T, Sudhakar G, Kiranmai D, Sasank R, Sridharreddy D. Central giant cell granuloma of maxilla: a case report. Indian J Otolaryngol Head Neck Surg. 2013 Jul;65(Suppl 1):192-4. doi: 10.1007/s12070-012-0538-1. Epub 2012 Mar 21. PMID: 24427644; PMCID: PMC3718951.
Ahmed A, Naidu A. Towards better understanding of giant cell granulomas of the oral cavity. J Clin Pathol 2021;74:483–90. doi: 10.1136/jclinpath-2020-206858
Richardson J, Stanbouly D, Litman E, Lee KC, Philipone E. Central giant cell granuloma of the head & neck: A case report and systematic review. J Stomatol Oral Maxillofac Surg. 2021 Aug 17:S2468-7855(21)00164-6. doi: 10.1016/j.jormas.2021.08.004. Epub ahead of print. PMID: 34411774.
Ramesh V. "Central giant cell granuloma" - An update. J Oral Maxillofac Pathol. 2020 Sep-Dec;24(3):413-415. doi: 10.4103/jomfp.jomfp_487_20. Epub 2021 Jan 9. PMID: 33967473; PMCID: PMC8083441.
Camarini C, de Souza Tolentino E. Non-surgical treatment as an alternative for the management of central giant cell granuloma: a systematic review. Clin Oral Investig. 2021;26(2):2111-2132. doi:10.1007/s00784-021-04193-z
Mohan, R. P. S. et al. (2013) “Central Giant Cell Granuloma: A Case Report,” Case Reports, 2013(Jul22 1), p. 2013009903. doi: 10.1136/bcr-2013-009903.
Hillerup S, Hjørting-Hansen E. Aneurysmal bone cyst--simple bone cyst, two aspects of the same pathologic entity? Int J Oral Surg. 1978 Feb;7(1):16-22. doi: 10.1016/s0300-9785(78)80005-2. PMID: 418014.
Gomes CC, Diniz MG, Bastos VC, Bernardes VF, Gomez RS. Making sense of giant cell lesions of the jaws (GCLJ): lessons learned from next-generation sequencing. J Pathol. 2020 Feb;250(2):126-133. doi: 10.1002/path.5365. Epub 2019 Dec 18. PMID: 31705763.
Chrcanovic BR, Gomez RS, Freire-Maia B. Neurofibromatosis type 1 associated with bilateral central giant cell granuloma of the mandible. J Craniomaxillofac Surg. 2011 Oct;39(7):538-43. doi: 10.1016/j.jcms.2010.10.014. Epub 2010 Nov 11. PMID: 21071237.
Edwards PC. Insight into the pathogenesis and nature of Central Giant Cell Lesions of the Jaws. Med Oral Patol Oral Cir Bucal. 2015 Mar 1;20(2):e196-8. doi: 10.4317/medoral.20499. PMID: 25681371; PMCID: PMC4393982.
Kerdoud O, Aloua R, Slimani F. Central Giant cell tumor of jaw bone in child: A case report. Int J Surg Case Rep. 2021 Feb;79:97-100. doi: 10.1016/j.ijscr.2021.01.007. Epub 2021 Jan 6. PMID: 33444967; PMCID: PMC7806938.
Flanagan AM, Speight PM. Giant cell lesions of the craniofacial bones. Head Neck Pathol. 2014 Dec;8(4):445-53. doi: 10.1007/s12105-014-0589-6. Epub 2014 Nov 20. PMID: 25409853; PMCID: PMC4245408.
Tecco, S., Caruso, S., Nota, A. et al. Bilateral Central Giant Cell Granuloma of the mandibular angle in three females from the same family. Head Face Med 14, 14 (2018). https://doi.org/10.1186/s13005-018-0171-7
Bayar OF, Ak G. Treatment of giant cell granuloma with intralesional corticosteroid injections: a case report. J Istanb Univ Fac Dent. 2015 Oct 21;49(3):45-50. doi: 10.17096/jiufd.88120. PMID: 28955545; PMCID: PMC5573504.
De Lange J, van den Akker H, van den Berg H. Central giant cell granuloma of the jaw: a review of the literature with emphasis on therapy options. Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontology. 2007;104(5):603-615. doi:10.1016/j.tripleo.2007.04.003
Pogrel M. Calcitonin therapy for central giant cell granuloma. Journal of Oral and Maxillofacial Surgery. 2003;61(6):649-653. doi:10.1053/joms.2003.50129
4. Kaban L, Dodson T. Regarding “Denosumab for the management of central giant cell granuloma of the jaws—a case series”. Int J Oral Maxillofac Surg. 2021. doi:10.1016/j.ijom.2021.09.012